Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

2025 Vol. 45, No. 8

Cover Catalogue
Reviews
Research progress on the treatment role and chemical synthesis methods of isoselenoazolones
WANG Wentao, GAO Xing, ZHAO Fengping, ZHENG Canhui, CHEN Xin
2025, 43(8): 367-372. doi: 10.12206/j.issn.2097-2024.202308064
Abstract(9508) HTML (4830) PDF (1044KB)(34)
Abstract:
Glutathione peroxidase (GSH-Px) is a key selenoenzyme that protects the body from oxidative damage. A series of small molecular organic selenium compounds have been designed and synthesized as functional mimics of GPx, among which isoselenazolones are the most widely studied. Taking ebselen as a representative, the catalytic mechanism of isoselenazolones in mimicing GSH-Px activity in vivo, the therapeutic effects of isoselenazolones in stroke, sensorineurium deafness and tinnitus, treatmentresistant depression (TRD) and coronavirus disease 2019 (COVID-19), and research on their chemical synthesis methods were summarized and discussed in this paper.
Influencing factors and optimization methods of pre-treatment for microbiological counting method of proprietary Chinese medicine
XIAO Nong, LU Shiyi, TANG Wenya, JU Minli, XU Gangfeng, YANG Minghua
2025, 43(8): 373-376, 409. doi: 10.12206/j.issn.2097-2024.202403014
Abstract(15428) HTML (7068) PDF (1252KB)(39)
Abstract:
Due to the diverse composition and complex physicochemical and biological characteristics, the pre-treatment of microbiological counting method (preparation of test solution) in microbiological limit test were interfered by many factors, which ultimately affected the repeatability and accuracy of test results. Improving the accuracy of microbiological test is of practical significance to ensure the safety and effectiveness of non-sterile preparations. In this paper, the key factors and optimization methods involved in the pre-treatment of proprietary Chinese medicines were systematically analyzed and summarized.
Original articles
The mechanism of Medicoscab tincture in the treatment of second-degree burns based on network pharmacology and molecular docking technology
ZHANG Qiang, LI Jing, LIU Yue, CHU Xiaoqin
2025, 43(8): 377-382, 399. doi: 10.12206/j.issn.2097-2024.202307014
Abstract(21472) HTML (8326) PDF (3313KB)(129)
Abstract:
  Objective   To explore the mechanism of Medicoscab tincture in the treatment of second-degree burns based on network pharmacology and molecular docking technology.   Methods   The effective components of the tincture were screened by the TCMSP; the effective components of the tincture and burn related targets were screened by GeneCards and OMIM database; Cytoscape 3.7.2 software was used to draw “Chinese medicine-disease-effective components-targets” network diagram; the related gene ontology (GO) functions and pathways of the tincture were obtained through GO enrichment analysis and Kyoto encyclo-pedia of genes and geomes (KEGG) pathway analysis on the targets through Metascape platform; the pathway bubble diagram was constructed by the pathways enriched in the KEGG database, and finally verified by AutoDockTools for molecular alignment.   Results  19 effective components and 179 target intersections of Medicoscab tincture were selected. GO analysis showed the intervention burns process mainly involved the reaction of inorganic substances, the reaction of cells to nitrogen compounds, and the response to xenobiotic stimuli, as well as biological processes such as membrane rafts, vesicular cavities, transcriptional regulatory factor complexes, receptor complexes, and endoplasmic reticulum cavities. KEGG analysis showed the function mainly includes AGE-RAGE signal pathway, PI3K-Akt signal pathway, IL-17 signal pathway, TNF signal pathway, etc. Analysis of cytoscape software showed the core targets were AKT1, TNF, IL-6, GAPDH, TP53, etc. Molecular docking showed that the active components of Medicoscab tincture were docking with multiple targets, among which β- sitosterol had strong binding activity with AKT1, GAPDH and TP53.   Conclusion   Quercetin, kaempferol, baicalein, β-sitosterol and other core active ingredients in the tincture of making scabs, which could assist in the relief of burns, regulate the signalling pathways such as AGE-RAGE, PI3K-Akt, IL-17, TNF and so on by acting on the targets of AKT1, GAPDH, TP53, IL-6 and so on. This study laid a theoretical foundation for clarifying the mechanism of action of tincture of scab making for the treatment of burn-like diseases.
Meta-analysis of external treatment by Traditional Chinese Medicine for skin pruritus induced by eczema
CHEN Tingru, GU Qinwufeng, WU Yunyang, MENG Yuanyuan, YANG Yanlong, LI Ruimin
2025, 43(8): 383-389. doi: 10.12206/j.issn.2097-2024.202504013
Abstract(18252) HTML (6607) PDF (2856KB)(33)
Abstract:
  Objective   To evaluate the clinical efficacy of Traditional Chinese Medicine (TCM)external treatment methods in alleviating skin pruritus caused by eczema through a Meta-analysis.   Methods   Randomized clinical trials investigating the use of TCM external treatment methods for skin pruritus caused by eczema were searched in databases including China National Knowledge Infrastructure (CNKI), VIP, Wanfang, Sinomed, PubMed, Embase, LILACS, and Cochrane, up to December 2024. Two reviewers independently screened and entered the statistical data, conducted bias risk assessment by the Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0, and performed Meta-analysis using RevMan 5.4.1.   Results   Ultimately, 14 studies involving 1 788 patients were included. Compared to the control group, TCM external treatment methods (treatment group)showed better improvement in pruritus scores (Z=11.88, P<0.000 01), better improvement in Eczema Area and Severity Index (EASI) scores (Z=23.15, P<0.000 01), higher overall clinical efficacy rate (Z=6.21, P<0.000 01), better improvement in TCM symptoms (Z=5.49, P<0.000 01), and lower clinical recurrence rate (Z=2.88, P=0.004). Three of the included studies mentioned adverse reactions, with the treatment group showing lower adverse reactions than the control group.   Conclusion   The external treatment of TCM was more effective in treating skin pruritus caused by eczema compared to the control group. Given the biases and heterogeneity in the included literature, this conclusion needs to be further substantiated by more large-scale, multi-center, randomized, controlled, and double-blind studies.
Quantitative analysis of 10 components in Compound Dihuang oral solution by UPLC-MS/MS
LIU Hongxia, SUN Yanwen, HAN Fei, ZHOU Yan, SUN Huajun, DING Liqin
2025, 43(8): 390-394. doi: 10.12206/j.issn.2097-2024.202312068
Abstract(6266) HTML (2626) PDF (1182KB)(43)
Abstract:
  Objective  To develop an ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method to simultaneously determine 10 main components, including berberine, phellodendrine, specnuezhenide, mangiferin, loganin, paeoniflorin, geniposide, baicalin, and acteoside in Compound Dihuang oral solution.   Methods  An UPLC-MS/MS method was established with an ACQUITY UPLC BEH-C18 (2.1 mm×100 mm, 1.7 μm)column and mobile phase of 0.1% formic water(A)-methanol solution(B) in a gradient elution manner. The flow rate of mobile phase was 0.2 ml/min.The temperature of column was 30℃. The injection volume was 2 μl. The MS detection was in MRM mode.   Results  10 components in Compound Dihuang oral solution had a good linear relationship within their concentration range,and the precision, repeatability, stability and recovery met the requirements. The contents of berberine, phellodendrine, specnuezhenide, mangiferin, loganin, paeoniflorin, geniposide, baicalin, and acteoside in 7 batches of samples were (89.7-95.6) μg/ml, (164.0-177.7) μg/ml, (540.0-610.0) μg/ml, (408.7-429.0) μg/ml, (726.0-825.0) μg/ml, (503.7-572.0) μg/ml, (1380.0-1540.0) μg/ml, (2596.7-2896.7) μg/ml, (4866.7-5520.0) μg/ml, (61.8-67.2) μg/ml, respectively.   Conclusion  The established method was easy to be repeated and operated. The contents of 10 components in Compound Dihuang oral solution could be determined quickly and accurately, which provided a reference for the quality control of hospital preparation.
Study on the characteristic chromatogram of Shexiang Jiegu Capsule and determination of seven components by HPLC
YU Xiaocui, WANG Xiwen, ZHANG Guiying, XU Junwei, ZHU Yuwei, HU Dan
2025, 43(8): 395-399. doi: 10.12206/j.issn.2097-2024.202307059
Abstract(6327) HTML (2862) PDF (1511KB)(23)
Abstract:
  Objective   To establish the characteristic atlas of Shexiang Jiegu Capsule and determine the contents of seven active components (hydroxysafflor Yellow A, paeoniflorin, ferulic acid, naringin, ligustilide, catechin, epicatechin).  Methods  Octadecyl silane bonded silica gel was used as the filling agent, the mobile phase was composed of methanol-0.05% phosphoric acid by gradient elution, the detection wavelength was 245 nm, flow rate was 1.0 ml/min, column temperature was 30℃. The similarity of the fifteen batches of sample was evaluated in line with the TCM Chromatographic Fingerprint (2012 edition), and the contents of seven active components were determined.   Results  The HPLC fingerprint of Shexiang Jiegu Capsules was established. The similarity of fingerprint between fifteen batches of samples and control fingerprint was between 0.893 and 0.992. The results of methodological investigation for the determination of seven active components in fifteen batches of samples all met the requirements.   Conclusion  The established characteristic atlas of Shexiang Jiegu Capsules had high specificity and good repeatability, which could provide scientific basis for quality control of Shexiang Jiegu Capsules.
Synthesis and antitumor activity of novel RRx-001 derivatives
WU Ruonan, TANG Wenmin, GAO Lin, WU Yuelin, LUO Chuan, MIAO Zhenyuan
2025, 43(8): 400-403. doi: 10.12206/j.issn.2097-2024.202408053
Abstract(8133) HTML (3295) PDF (938KB)(34)
Abstract:
  Objective  To study the antitumor activities of RRx-001 derivatives with novel covalent fragments.   Methods  Four targeted compounds were designed and synthesized. The structures were confirmed by 1H NMR and HRMS. A549 and HCT116 cancer cell lines were selected for antiproliferative activity assays.   Results   All the compounds revealed antitumor activities and compound ZM528 showed the best antitumor activity against these two cell lines with IC50 values of (5.1±4.8) μmol/L and (6.0±2.7) μmol/L, respectively.   Conclusion  The result indicated that bromoacetyl group of RRx-001 could be substituted with other covalent fragments.
Pharmacy administration
Data mining of current research status of clinical trial drug management in China by bibliometrics
XU Chang, ZHOU Xinna, QI Lu, WANG Yu, WANG Xinghe
2025, 43(8): 404-409. doi: 10.12206/j.issn.2097-2024.202404050
Abstract(15100) HTML (2589) PDF (1600KB)(22)
Abstract:
  Objective  To clarify the current development status and research hotspots in the field of experimental drug management in China through data mining by bibliometric.   Methods  Key words such as “experiment”, “drug”, and “management” were used to search the Chinese literature in China National Knowledge Infrastructure (CNKI). The title, author name, author affiliation, Chinese abstract, Chinese keywords, publication period, journal name, and other content of the literature were extracted from the literature. Cluster analysis was performed by CNKI literature visualization analysis system, CiteSpace and other software, and a network knowledge map was drawn.   Results  The literature in the field of experimental drug management in China was first published in 1994, and a total of 140 articles were published until 2022. Among them, 20 articles were supported by relevant funds, and the keyword co-occurrence frequency was highest among “subjects”. The most frequently published medium was the Chinese Pharmacological Yearbook.   Conclusion  At present, the quantity and quality of literature in the field of experimental drug management in China were relatively small, and the cooperation and communication among authors were not close. The funding from various fund projects in this field was also lacking. These factors led to a lower overall development level and slower development speed in this field.
Cost-effectiveness analysis between sodium valproate and levetiracetam in the treatment of childhood epilepsy
SHAO Wei, YUAN Ni, LIU Ye, YU Fei, LIU Ying, WANG Feng
2025, 43(8): 410-413, 420. doi: 10.12206/j.issn.2097-2024.202408046
Abstract(9396) HTML (6646) PDF (1306KB)(31)
Abstract:
  Objective   To compare the cost-effectiveness between sodium valproate and levetiracetam in the treatment of childhood epilepsy and provide an economic basis for clinical medication choices.   Methods   A cost-effectiveness analysis was conducted using a decision tree model to compare the effectiveness and drug costs of sodium valproate and levetiracetam in treating childhood epilepsy. Single-factor sensitivity analysis and probabilistic sensitivity analysis were used to assess the impact of parameter variations on the study results.   Results   The treatment cost of levetiracetam was significantly higher than that of sodium valproate. The incremental cost-effectiveness ratio (ICER) of levetiracetam compared to sodium valproate was ¥8 628.43. Sensitivity analysis results were consistent with the base-case analysis. The probabilistic sensitivity analysis showed that, over a 6-month treatment period, levetiracetam became a more cost-effective option when the willingness-to-pay (WTP) threshold was ¥9,000 or higher. One-way sensitivity analysis revealed that the price of levetiracetam was the most influential factor affecting the ICER.   Conclusion   When the WTP per effective pediatric epilepsy case is ¥9,000 or higher, levetiracetam demonstrates a cost-effectiveness advantage.
Literature analysis of rhabdomyolysis induced by bezafibrate
YANG Qiuya, LIU Xia
2025, 43(8): 414-420. doi: 10.12206/j.issn.2097-2024.202404081
Abstract(7971) HTML (3485) PDF (955KB)(14)
Abstract:
  Objective   To analyze the causes of adverse reactions induced by bezafibrate, study the clinical characteristics of rhabdomyolysis, and provide reference for clinical rational use.   Methods  The case reports of bezafibrate induced rhabdomyolysis were collected from domestic and foreign databases (from January 1, 2000 to November 30, 2023), and the relevant basic data were extracted for statistical analysis. The rationality and adverse reaction relevance of bezafibrate use which met the inclusion criteria were evaluated.   Results  A total of 26 cases of bezafibrate induced rhabdomyolysis were reported, including 28 patients. There were 10 males and 18 females, with an average age of (64.57±11.20) years, the occurrence time of adverse reaction was 6 d(4 d, 8.5 d). All patients had other diseases except hyperlipemia. The creatinine clearance rate (CCR) of patients was generally less than 80ml/min. There were 16 patients were given over-dosed bezafibrate.   Conclusion  The drug instruction of bezafibrate should be regulated and managed by National Regulatory Authority. In clinical application, attention should be paid to the rationality of medication use, ADR monitoring and patient education.